How microplastics affect radiation treatment for head and neck cancer
Part of Cancer clinical trials.
This study looks at how tiny plastic particles (microplastics) in your body might affect your response to radiation therapy for head and neck cancer. You might be eligible if you have head and neck cancer and are about to start radiation, with or without the chemo drug cisplatin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have any stage of head and neck cancer.
- You are well enough to be up and about (ECOG 0-2), meaning you can care for yourself and do daily activities.
- You are scheduled to receive radiation therapy, with or without the chemotherapy drug cisplatin.
- You are willing and able to sign a consent form to participate.
- You are not pregnant or breastfeeding.
- You do not have a serious mental illness that could interfere with the study.
- You have not had other cancers before or at the same time (except head and neck).
- You are not receiving immunotherapy or drugs that suppress your immune system.
- You do not have an immune system disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new way to use radiation therapy for head and neck cancer by also looking at the bacteria in your mouth and gut. The goal is to see if adjusting the treatment based on your bacteria can improve outcomes and reduce side effects.
This trial studies an anti-cancer gel that delivers cisplatin directly into a head and neck tumor with a single injection. It mainly checks safety and side effects, and also looks for early signs that the tumor responds in people whose cancer is progressing or no longer responds to standard treatment.
This study tests a health-focused skin care plan to prevent or treat skin irritation from radiation therapy. If you're getting radiation (with or without chemo) for head and neck or pelvic cancer, this trial may help manage side effects.
This study looks at immune system signals in your blood during and after postoperative radiation therapy for certain head and neck cancers involving the brain or skull base. Researchers want to see whether these “immune markers” relate to treatment response or side effects.
This study looks at how radiotherapy, and possibly cisplatin chemotherapy, affect hearing in people treated for head and neck cancer. It may help doctors better predict hearing side effects and plan hearing monitoring or prevention.
This study is testing how well a combination of chemotherapy (cisplatin) and radiation therapy works for certain head and neck cancers that have spread to lymph nodes. Doctors will use MRI, CT, and PET scans to predict how the cancer responds to treatment.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.